Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).
Cancers (Basel)
; 13(11)2021 Jun 03.
Article
in En
| MEDLINE
| ID: mdl-34204877
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Risk_factors_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2021
Type:
Article
Affiliation country:
Italy